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Abstract
Background: Numerous studies were performed to illuminate mechanisms of tumorigenesis and metastases from gene
expression profiles of Head and Neck Squamous Cell Carcinoma (HNSCC). The objective of this review is to conduct a
network-based meta-analysis to identify the underlying biological signatures of the HNSCC transcriptome.
Methods and Findings: We included 63 HNSCC transcriptomic studies into three specific categories of comparisons: Pre,
premalignant lesions v.s. normal; TvN, primary tumors v.s. normal; and Meta, metastatic or invasive v.s. primary tumors.
Reported genes extracted from the literature were systematically analyzed. Participation of differential gene activities across
three progressive stages deciphered the evolving nature of HNSCC. In total, 1442 genes were verified, i.e. reported at least
twice, with ECM1, EMP1, CXCL10 and POSTN shown to be highly reported across all three stages. Knowledge-based networks
of the HNSCC transcriptome were constructed, demonstrating integrin signaling and antigen presentation pathways as
highly enriched. Notably, functional estimates derived from topological characteristics of integrin signaling networks
identified such important genes as ITGA3 and ITGA5, which were supported by findings of invasiveness in vitro [1].
Moreover, we computed genome-wide probabilities of reporting differential gene activities for the Pre, TvN, and Meta
stages, respectively. Results highlighted chromosomal regions of 6p21, 19p13 and 19q13, where genomic alterations were
shown to be correlated with the nodal status of HNSCC [2].
Conclusions: By means of a systems-biology approach via network-based meta-analyses, we provided a deeper insight into
the evolving nature of the HNSCC transcriptome. Enriched canonical signaling pathways, hot-spots of transcriptional
profiles across the genome, as well as topologically significant genes derived from network analyses were highlighted for
each of the three progressive stages, Pre, TvN, and Meta, respectively.
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Introduction
Head and Neck Squamous Cell Carcinoma (HNSCC), ranked
the 6th common cancer worldwide, has long been recognized with
a heterogeneous clinical presentation and a poor prognosis in
advanced stages [3]. Historically, decisions to pursue aggressive
treatments such as chemoradiotherapy (CRT) or neck dissection,
to a very large extent, depended on clinical staging. Many patients
suffered from treatment failure due to local recurrence, distant
metastases, or the development of second primary HNSCC, even
with the utilization of multi-modality treatment options [4].
Nevertheless, understanding mechanisms of tumorigenesis and
metastatic progression remains as the most urgent call for future
remedy of HNSCC.
Recent advance in using microarray technology to investigate
HNSCC cancer biology has attracted significant research interest.
Choi and colleagues [5], who took the lead in systematically
summarizing the HNSCC transcriptome, discovered such signif-
icant biological pathways as cell cycle regulation, inflammatory
response, mevalonate pathway, and down-regulation of genes
encoding cytoplasmic ribosomal proteins. These reconfirmed or
newly discovered pathways shed light on the pathophysiology of
HNSCC.
Graphical presentations of biological networks become a
common platform to demonstrate gene–gene interplays and to
model human diseases at systems-level [6]. Integrative meta-
methods, which utilize genomic, proteomic and phenotypic
information from various sources, have been shown reliable in
generating novel experimental hypotheses [7,8]. However, an
integrative approach of network analysis and systems biology has
not been applied to HNSCC.
We recently developed a knowledge-based network approach to
conduct genomic meta-analysis of HNSCC [9]. This article,
aiming to depict the evolving transcriptome of HNSCC via
comparisons of gene expression profiles, sought to dissect the
progressive states of HNSCC by examining the following three
comparisons: Pre, premalignant lesions v.s. normal; TvN, primary
tumors v.s. normal; and Meta, disseminated (regional lymph node
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localized tumors.Results inthe original articles were demonstrated to
identify patterns of etiologic or metastatic processes of HNSCC in
terms of Pre, TvN,o rMeta. Here, we synthesized results of differential
gene expression profiles into knowledge-based interacting networks.
It was designated that the evolving nature of HNSCC could be read
out from the topological characteristics, the prismatic visualization of
three staged interacting networks, and the probabilities of reporting
differential gene activities across the genome.
Methods
Search Strategy
We conducted this meta-analysis in accordance with the
standard protocol recommended by the Quality of Reporting of
Meta-analyses group [10]. A systematic search in the PubMed
database (Jan 1994 to Apr 2008) was performed using a complex
query, consisted of keywords ‘‘head and neck neoplasm’’, ‘‘gene
expression profiling’’, ‘‘oligonucleotide array sequence analysis’’,
‘‘microarray’’ and ‘‘carcinoma, squamous cell’’. Details of the
complex query were provided in Text S1. A total of 410
potentially relevant articles were identified. First, we excluded
studies examining lesions located in thyroid glands (n=82),
salivary glands (n=16), nasopharynx (n=23), eyes or elsewhere
(n=5). Studies were further excluded if the primary data reported
was not differential gene expression profiling (n=118), or if the
samples used in the experiment were not human tumor tissue
(n=96). Of the remaining 70 studies, six were examining HPV-
related or smoking-related transcriptional profiles and one was
unavailable. Sixty-three studies of transcriptional profiles of
HNSCC were included in the meta-analysis and classified into
three specific comparisons: Pre, premalignant lesions v.s. normal
(n=5); TvN, primary tumors v.s. normal (n=41); and Meta,
disseminated (regional lymph node involvement, distant metasta-
ses, or local recurrence) v.s. primary localized tumors (n=26).
Figure 1 demonstrated the QUOROM flow diagram of screening
microarray-based HNSCC transcriptional profiles.
Data extraction, processing and parsing
For each study, reported genes were extracted from tables, text
or supplements. We converted various kinds of gene or sequence
identifiers, such as UniGene cluster IDs, Genbank accession
numbers, gene symbols, or Affymetrix probe sets, into the
universal Entrez GeneIDs. GeneIDs conversion was done by the
web-based program of DAVID2007–2008 (Database for Annota-
tion Visualization and Integrated Discovery, NIH) [11]. Then, for
each article, we compiled information of the PubMed ID, the
original identifiers, the converted Entrez GeneIDs, and the values
or directions of fold changes into a standard format (Text S1).
Program scripts were developed for the use of ActivePerl and R
statistical software (version 2.6.1) in text processing, parsing
networks (svg files), analyzing and comparing the gene lists,
linking gene-specific information and chromosomal coordinates,
and transforming gene-gene interactions into matrices for
networks topological analyses. Cytoscape software (version 2.5.1)
was used for the illustration of networks [12].
Quantitative data synthesis: bounded fold changes
In order to synthesize the original information of fold changes, a
novel method was developed to overcome differences in multiple
microarray platforms. This method based on the assumption that
different transcriptional measurements of the same target gene, i.e.
different sequence or gene identifiers converted into the same
Entrez GeneID, were indeed representing the same functional
entity. For each study, if fold changes, h, were reported, the
standardized bounded fold changes would be |h9|=h/(maximum
of h) with regard to up- and down-regulated genes separately;
alternatively, if only directions of up- or down-regulation were
reported, the bounded fold changes would be translated into 1 for up
and 21 for down, respectively. For each of the Pre,TvN or Meta stages,
consensus of gene expression was computed as the averaged mean of
the bounded fold changes if studies reported values of fold changes;
else, the median was computed instead if at least one study reported
only directions of gene regulation. Genes without such information
were coded with 0 as the bounded fold changes in the analysis.
Validity assessment
Owing to the underlying heterogeneity among included studies,
such as differences in the tumor of origins (oral, pharynx, or
larynx), multiple microarray platforms, different analytical ap-
proaches taken, and diverse endpoints, we sought to examine the
validity of three staged classification of the HNSCC transcriptome.
First, we systematically computed the frequency of reporting the
same Entrez GeneID within each stage of comparison. If a gene
was reported more than once, this gene was regarded as verified.
Subsequently, the validity of TvN and Meta was tested through
comparisons of ratios of internal consistency, defining as the
percentage of verified genes for each study within the groups of
interest, i.e. studies of lesions in different subsites, studies using
Figure 1. QUOROM flow diagram of the systematic reviews and
meta-analysis. The diagram summarized the search strategy. In order
to be included, studies had to examine the HNSCC tumor samples by
means of microarray-based gene expression profiling.
doi:10.1371/journal.pone.0003215.g001
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points, or the proposed classification. Classifying studies in TvN or
Meta would be considered reasonable if the ratios of consistency
were higher than those within the subgroups of interest. For
instance, of the 121 differentially expressed genes by Ibrahim and
colleagues, 74 genes (61%) were verified when classified in TvN;3 8
genes (32%) verified among the 23 studies using cDNA microarrays
in TvN; as well as 32 genes (27%) verified among the 19 studies
examining tumors located exclusively in the oral cavity.
Knowledge-based network analyses and identification of
enriched canonical pathways
The bounded fold changes of the full gene lists and the verified
gene lists of three comparisons, Pre, TvN, and Meta, were imported
into the Ingenuity Pathways Analysis (IPA) Software (Ingenuity
Systems, Redwood City, CA, USA) to obtain six sets of networks
for further analyses. We used IPA to identify the top 10 enriched
canonical pathways for each stage of comparison (Fig. 2). The
enriched canonical pathways were ranked by the p-values of the
Fisher’s exact test, which indicated the probabilities of the input
genes to be associated with genes in the canonical pathways
expected by chance.
Networks generated from the IPA consisted of identified focus
genes from the user input and other correlated molecules or genes
from the knowledge base [13]. Networks were scored and ranked
according to the probabilities of having more focus genes than
expected by chance. To gain a comprehensive perspective of the
HNSCC transcriptome, three sets of networks generated from the
IPA analyses with the full gene lists as inputs were parsed and
merged into three staged interacting networks, representing the
Pre, TvN, and Meta progressive states of HNSCC. Only networks of
scoring higher than 10 (log p-value) were included in the analysis.
Network topological analyses
Based on findings in model organisms, indicating that network
structure such as dynamic modularity [14] and topological
cartography [15] determined the key aspects of regulation and
functionality, we developed a new framework of network
topological analyses to estimate the implied pathological effect
for each gene in the HNSCC transcriptome. The idea was to
evaluate the functional significance of a gene based on the concept
of connectivity. An inter-modular hub-designated as a cut node in
the graph - would cause the original component breaking down
into different blocks upon removal of itself, leading to the blockade
of signaling crosstalk. If an inter-modular hub i was disrupted, i.e.
removed in the interacting network, we estimated the potential for
pathophysiological perturbation by the informational score (fi),
computed by the number of blocked out paths divided by the
number of breaking down components. The informational score
(fi) was calculated as equation (1), where m denoted the number of
broken-down components after removing a node i, Ncp denoted
the total number of nodes in this component where node i was
located, S was the size of each broken-down component, and m.lg
was the iterating counter part for each S to calculate the blocked-
out paths.
if m~1
fi~0
m:lg0 ~Ncp{1
if mw1
m:lgk ~m:lgk{1 {Sk
fi~
P m
k~1
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m
8
> > > > > > <
> > > > > > :
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Rest of the genes were grouped into the periphery genes or the
intra-modular hubs, whose interactions were equal or greater than
two and whose removal would NOT cause the breakdown of
networks. We did not consider the pathophysiological effects of
these two groups of genes based on the topological properties.
Sub-networks of enriched canonical pathways were extracted
from each of the three progressive stages of the HNSCC
transcriptome for independent topological analyses (Fig. 3a–i).
Prominent connecting hubs were identified by the topological
characteristics, changes in the transcriptional profiles, or the
participation among different stages of the HNSCC transcriptome.
Probabilities of reporting differentially expressed genes
within each cytoband along the chromosomal
coordinates
Across the genome, we computed the accumulative probabilities
(PB) of reporting genes within the chromosomal segments for each
stage of comparisons. For instance, in the TvN comparison
consisted of 41 papers, the cumulative probability of a cytoband
with k genes reported would be PB~
X k
g~1
fqg
41
, where fqg was the
number of articles reporting gene g in TvN. In order to compare
across three progressive stages, we standardized PB of the Pre, TvN,
and Meta to be within 0,1 by dividing the maximum probability
of each stage. We plotted PBs of three progressive stages along the
chromosomal coordinates to identify hot-spot regions. For the
identified hot-spots, differential gene activities (bounded fold
changes) were illustrated on the resolution of a single gene for
each stage of comparison.
Results
Consensus among genes reported in each stage of
comparison
There were 1822, 4311, and 2293 genes, respectively, reported
from 5, 41, and 26 papers in the Pre, TvN, and Meta comparisons.
Eighty-two genes out of 1822, 1260 out of 4311, and 321 out of
2293 were found reported at least twice in the Pre, TvN, and Meta
comparisons. With regard to the direction of fold changes of the
verified genes, we found the least contradiction in TvN (217/
1260=17.2%), less in Meta (117/321=36.5%), and the most, in
Pre (42/82=51.2%). There were few genes overlapped between
Pre and Meta, whereas many overlapped between any other pairs
of comparisons. In Table 1, reported genes were listed according
to the number of reporting studies for each stage of comparison.
Notably, MMP1, reported 13 times in TvN with a bounded fold
change of 1, was found consistently highly up-regulated, albeit that
tumors were harvested from different anatomical subsites; whereas
in the Meta comparison, we found MMP1 with three studies
reporting induced [16,17,18] and one repressed [19]. We
speculated that the contradictory regulation of MMP1 in Meta
might stem from differences in prognostic endpoints investigated
rather than the lesion sites.
Validity of the TvN and Meta progressive stages of the
HNSCC transcriptome
We found a higher internal consistency, i.e. having a higher
ratio of the verified genes, among studies in TvN (mean
ratio=71%), secondly in Meta (31%), and lastly in Pre (26%)
(Table 2). In TvN, we further investigated ratios of consistency
within subgroups of studies examining tumors from distinct
anatomical subsites (p, pharynx; L, larynx; and o, oral cavity) or
tumors from unspecified locations (mix). Nineteen papers procured
Evolving Transcriptome: HNSCC
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we found a significant decrease of the internal consistency within
this subgroup (mean ratio=37%). Gene lists reported from distinct
anatomical subsites were examined in details (Text S1). The
majority of genes reported from tumors of distinct oral cavity
(63%), pharynx or larynx (74%) overlapped with those from
unspecified locations. There were 94 genes reported in common
from distinct and mix groups; 58 genes specific to pharynx or
larynx; and 376 genes specific to oral cavity. Particularly, 98 genes,
accounting for 9.6% from oral cavity as well as 41% from pharynx
or larynx, overlapped and suggested that some similarities existed
among the distinct groups. We also noted decreases of internal
consistencies within subgroups of studies using similar microarray
platforms. In general, studies using Affymetrix Genechips
demonstrated higher internal consistencies. Three studies using
Affymetrix HG-U95A and 4 studies using Affymetrix HG-U133
held with more overlap in the findings; however, another four
studies using Affymetrix HG-U95Av.2 did not. Taken cDNA
Figure 2. Ranking of the enriched canonical pathways. Eight canonical pathways were found in consensus in IPA with the full gene lists (all) or
the verified gene lists (fq2) as inputs. Embedded table showed rankings of the canonical pathways in different analyses. Antigen presentation,
calcium signaling, and integrin signaling pathways were highlighted as highly enriched across three progressive stages. For each stage of the HNSCC
transcriptome, figure panels demonstrated the enriched canonical pathways ranked by the 2log (p-values) (right y-axis), that is, the orange line with
square data points. Colored bars were indicating the percentage (left y-axis) of the up- or down-regulated genes within each canonical pathway. The
numbers on top of the colored bars were the number of total genes in the canonical pathways.
doi:10.1371/journal.pone.0003215.g002
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level of consistency while the rest showed considerable decreases
(data not shown). It was of importance to be reminded that the size
of the reported gene lists would certainly affect the ratio of
consistency. Details of the numbers and anatomical subsites of
procured tumor samples, microarray platforms used, analytical
methods conducted, original identifiers reported, information
regarding fold changes, and the availability of datasets were
provided in Table S1.
With regard to differences of prognostic outcomes investigated
in Meta, we classified studies into 4 subgroups (pN, positive lymph
nodes; recur, recurrence; dM, distant metastasis; and surv, survival).
Similar to the results in TvN, ratios of internal consistencies within
each subgroup dropped significantly, especially in the dM and surv
group (mean ratio=23%, 5%, 5% for pN, dM, and surv subgroups,
respectively). Overall, we believed that classification of three
progressive stages, Pre, TvN and Meta, of the HNSCC transcrip-
tome was sufficient for the purpose of this meta-analysis.
The global HNSCC transcriptome in Pre, TvN, and Meta
For reasons of the inherent noise in the HNSCC transcriptome,
we developed a strategy to capture the essential themes by
focusing on the enriched signaling pathways as well as the
topological properties of the interacting networks. In the verified
gene lists, findings were more stably shown in HNSCC but the
scope might be too limited. In contrast, using the full gene lists
might facilitate findings of significant modules, which might be
obscure when data were scarce. Therefore, the bounded fold
changes of the full gene lists and the verified gene lists of Pre, TvN,
and Meta were first imported into IPA to obtain six sets of
networks. We compared these two levels of analyses to come up a
consensus of the enriched signaling pathways. The interacting
networks of the HNSCC transcriptome were ultimately built on
those generated by the full gene lists. Networks of scoring higher
than 10 (log p-value) were parsed and merged into three staged
interacting networks, representing the Pre, TvN, and Meta
progressive states of HNSCC.
Figure 3. Enriched antigen presentation and integrin signaling pathways in each stage of comparison of the HNSCC transcriptome.
Genes were represented by nodes and functional associations by edges. Node coloring was scaled to the bounded fold changes–red: up-regulated;
green: down-regulated. Node size was proportional to the number of papers reporting this gene in the HNSCC transriptome. Edges were colored
according to the stage of the HNSCC transcriptome–red: Meta; blue: TvN; and green: Pre. a–c. Merged networks of the antigen presentation pathways
with nodes colored according to the bounded fold changes in Pre, TvN, and Meta, respectively. d–f. Merged networks of the integrin signaling
networks with nodes colored according to the bounded fold changes in Pre, TvN, and Meta, respectively. g–i. Sub-networks of the integrin signaling
pathway in the Pre, TvN and Meta stages of the HNSCC transcriptome. (For details, please see Figure S1, S2, S3, S4 and S5).
doi:10.1371/journal.pone.0003215.g003
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A total of 65, 100 and 64 networks were merged into the Pre, TvN
and Meta interacting networks, respectively. The density (average
degree) of the networks was similar for each stage, and all of them
contained a major component (a connected subset) of the size
around 2000 genes. We did network topological analyses and
identified significant inter-modular hubs with the highest infor-
mational scores. Likewise, intra-modular hubs of the highest
connectivity for each stage of comparison were also listed in
Table 3.
Consensus of the enriched canonical signaling pathways
Top 10 enriched canonical pathways resulted from the IPA
analysis using the verified gene lists were quite different from
t h o s eu s i n gt h ef u l lg e n el i s t s .T h e2log(p-values) of the
canonical pathways analyzed with the verified genes list were
more significant than those with the full gene lists. Figure 2
demonstrated the percentage of the up- and down-regulated
genes in each pathway and the 2log (p-value) of each pathway
was plotted in decreasing orders. The embedded table in
Figure 2 showed eight canonical pathways in consensus across
three progressive stages. Antigen presentation, calcium signaling
and integrin signaling pathways were highlighted as the top
ranked.
Enrichedantigenpresentationandintegrinsignalingpathways
We sought to explore the global HNSCC transcriptome by
looking into the enriched antigen presentation and integrin
signaling pathways (Figure 3). Emergent view of cancers as an
equilibrium state of the adaptive immunity confirmed the long
obscuring roles of immunoediting in tumorigenesis and metastasis
[20]. In the sub-networks of the antigen presentation pathway, we
identified three components, representing three major complexes–
proteasome, MHC class I, and MHC class II. Significant
repression of the transcriptional profiles in Meta was noted,
particularly HLA-G in MHC I and HLA-DRB1 in MHC II. CALR,
the endoplasmic reticulum-residing chaperone, calreticulin, was
found differentially expressed in Pre and Meta; and presented itself
as the hub connecting MHC I, the complement system, and
THBS1.
Network-based approach to address the complex mechanisms
underlying the integrin adhesome has been sought out by
researchers [21]. In the integrin signaling networks of the HNSCC
transcriptome, we identified several repressed inter-modular hubs:
ACTN2, CAPN3 and TTN in Pre and TvN; and ILK, RHO-G and
VCL in Meta. GRB2, ITGA5, ITGB6, ITGB7 and MAPK8 were
distinguished as topologically significant hubs in the TvN
interacting networks. Table S2 provided details of the topologi-
cally significant genes in the enriched antigen presentation and
integrin signaling networks.
Table 1. Highly reported genes with bounded fold changes in each stage of comparison.
Pre TvN Meta
gene fq chr fold gene fq chr fold gene fq chr fold
NR2F2 3 15q26 0.14 KRT4 18 12q12 20.73 TNC 6 9q33 0.03
EMP1 3 12p12.3 0.14 KRT5 16 12q12 20.72 PI3 5 20q12 21
TAP1 3 6p21.3 0.16 PLAU 15 10q24 0.48 SFRP4 4 7p14.1 0.19
COL6A3 3 2q37 0.14 FN1 14 2q34 0.45 PLEC1 4 8q24 0.51
GPRC5A 3 12p13 20.46 MAL 14 2cen-q13 20.96 MMP1 4 11q22.3 0.6
KRT1 2 12q12 20.35 MMP1 13 11q22.3 1 TRIM22 4 11p15 20.46
DPYSL3 2 5q32 20.42 COL1A2 13 7q22.1 0.4 SERPINB2 4 18q21.3 20.32
CRIP1 2 14q32.3 20.41 SPARC 13 5q31.3 0.43 FN1 4 2q34 0.44
CXCL10 2 4q21 0.67 POSTN 12 13q13.3 0.61 POSTN 4 13q13.3 0.71
IGJ 2 4q21 0.82 IFI6 12 1p35 0.33 DSG3 4 18q12.1 20.44
RBP1 2 3q23 0.59 TGM3 12 20q11.2 20.86 FGFBP1 4 4p16 20.19
IFI44 2 1p31.1 0.58 SPP1 11 4q21-q25 0.79 EGFR 4 7p12 20.29
CA2 2 8q22 0.56 ITGA6 11 2q31.1 0.26 TGM3 4 20q11.2 20.89
ADH7 2 4q23 20.16 KRT13 11 17q12-q21 20.53 PLAU 4 10q24 1
COL4A1 2 13q34 0.33 EMP1 11 12p12.3 20.48 ITGB4 4 17q25 20.32
COL6A1 2 21q22.3 0.22 ECM1 11 1q21 20.57 CHPT1 31 2 q 20.11
LOX 2 5q23.2 0.18 TNC 10 9q33 0.43 CDH3 3 16q22.1 0.32
FKBP1A 2 20p13 0.18 MMP10 9 11q22.3 0.75 KRT16 3 17q12 21
SEC23A 2 14q21.1 20.44 MMP3 9 11q22.3 0.59 PHC2 3 1p34.3 0.23
CTNND1 2 11q11 20.03 MMP12 9 11q22.3 0.55 RAC2 3 22q13.1 0
CLINT1 2 5q23.1 20.03 LAMC2 9 1q25-q31 0.55 GREM1 3 15q13 1
THY1 2 11q22.3 0.26 IL8 9 4q13-q21 0.73 GPC5 3 13q32 21
COL4A2 2 13q34 0.33 KRT17 9 17q12 0.39 KRT14 3 17q12 1
AK2 2 1p34 0.01 COL5A2 9 2q14-q32 0.43 MMP2 3 16q13 1
KRT10 2 17q21 0.13 COL4A1 9 13q34 0.37 LGALS1 3 22q13.1 1
Abbreviations: fq, the number of papers reporting a gene; chr, the chromosomal coordinate; fold, the consensus of the bounded fold changes.
doi:10.1371/journal.pone.0003215.t001
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integrin signaling pathways
Gaggioli and colleagues [1] established a new model to visualize
the collective invasion of co-cultured stromal fibroblasts and oral
carcinoma cells (SCC12). ITGA3, ITGA5, and the RhoGTPases
were required in the force-mediated matrix remodeling, by which
the leading stromal fibroblasts were able to generate tracks to
support SCC invasion. To exploit the biological significance of the
interacting networks in the enriched pathways, we compared the
topological informational scores of the integrin family with the
percentage of matrix contraction due to knockdown of integrins by
Table 2. Ratios of internal consistency of selected studies in each stage of comparison.
Articles in TvN ratio ratio site Articles in Pre ratio ratio site
Ye et al 289/316 0.91 o Kondoh et al 9/27 0.33 o
Suhr et al 92/175l 0.53 o Banerjee et al 69/1348 0.05 o
Braakhuis 44/59 0.75 mix Odani et al 11/18 0.61 o
Ziober et al 68/76 0.89 mix Carinci et al 21/159 0.13 o
Kainumai et al 8/10 0.8 mix Ha et al 59/357 0.17 mix
Gottschlich et al 12/22 0.55 pL
Tomioka et al 32/46 0.7 o Articles in Meta ratio ratio site category
Dysvik et al 29/50 0.58 mix Mendez et al 28/180 0.16 o p
Jarvinen et al 16/40 0.4 L Pramana et al 9/40 0.23 mix r
Roesch Ely et al 5/5 1 mix Carinci et al 9/38 0.24 L p
Belbin et al 107/208 0.51 o Chung et al 17/44 0.39 mix s
Schlingemann et al 46/63 0.73 p Vachani et al 53/92 0.58 mix d
Kornberg et al 91/113 0.81 op Zhou et al 16/48 0.33 o p
Carinci et al 7/27 0.26 o Nguyen et al 16/68 0.24 o p
Laytragoon-Lewin et al 8/12 0.67 mix Kato et al 3/19 0.16 o p
Chin et al 26/44 0.59 op Roepman et al 167/742 0.23 mix p
Shimada et al 2/9 0.22 o Carinci et al 20/125 0.16 o d
Irie et al 6/10 0.6 o Belbin et al 53/208 0.25 o p
Cromer et al 119/125 0.95 p O’Donnell et al 6/29 0.21 o p
Schmalbach et al 48/57 0.84 o Roepman et al 71/96 0.74 mix p
Ginos et al 902/2126 0.42 mix Irie et al 13/20 0.65 o p
Marcus et al 45/60 0.75 op Chung et al 70/180 0.39 mix p,s
Toruner et al 43/54 0.8 o Schmalbach et al 28/57 0.49 o p
Kuriakose et al 40/40 1 mix Warner et al 0/15 0 o p
Tsai et al 48/62 0.77 o Nagata et al 14/20 0.7 o p
Whipple et al 44/47 0.94 op Braakhuis et al 10/41 0.24 mix d
Ha et al 875/2041 0.43 oL Giri et al 8/39 0.21 mix d
Banerjee et al 5/5 1 o Talbot et al 14/65 0.22 mix d
Nagata et al 31/35 0.88 o Cromer et al 9/36 0.25 p d
Sok et al 195/231 0.84 mix Ginos et al 22/59 0.37 mix r
Gonzalez et al 5/7 0.71 o Ganly et al 4/16 0.25 mix s
Leethanakul et al 26/37 0.7 o Winter et al 30/154 0.19 mix s
Kuo et al 2/9 0.22 o Belbin et al 29/260 0.11 mix s
Ibrahim et al 74/121 0.61 o
Hwang et al 38/43l 0.88 o
El-Naggar et al 8/11 0.73 op
Mendez et al 244/305 0.8 op
Squire et al 11/13 0.85 o
Alevizos et al 41/42 0.98 o
Leethanakul et al 33/57 0.58 mix
Villaret et al 10/13 0.77 mix
Abbreviations: o, oral; p, pharynx; L, larynx; op, oral and pharynx; oL, oral and larynx ; pL, pharynx and larynx; mix, multiple tumor of origins; p, positive lymph node;r ,
recurrence; d, distant metastasis; s, survival.
Note: detailed references were provided in Table S1.
doi:10.1371/journal.pone.0003215.t002
Evolving Transcriptome: HNSCC
PLoS ONE | www.plosone.org 7 September 2008 | Volume 3 | Issue 9 | e3215siRNA in stromal fibroblasts (Table 4). With regard to eight
integrins, ITGA1, ITGA2, ITGA3, ITGA5, ITGAV, ITGA6, ITGB1
and ITGB4, the correlation between the topological informational
scores in TvN and the matrix contraction after the knockdown was
20.867 (Pearson correlation test, p-value=0.005). The informa-
tional scores derived from the topology of interacting networks
were developed to estimate the perturbed pathological effects, i.e.
blocked signaling information. Not all of the integrins were
differentially expressed across three stages; hence, we could not
correlate the estimated pathological effects beyond the TvN
networks. Nonetheless, based on the strong association between
the estimated biological significance and the experimental
findings, we are convinced that network-based meta-analyses of
the evolving HNSCC transcriptome could indeed recapitulate the
underlying nature of disease progression.
Genome-wide probabilities of reporting differential gene
activities in the evolving HNSCC transcriptome
In Figure 4, we plotted the standardized accumulative
probabilities (PBs) of reporting differentially expressed genes
within each chromosomal segment for the HNSCC transcriptome.
Several significantly reported regions were identified: 1p36, 1q21,
5q31, 6p21, 9q34, 11p15, 11q13, 12p13, 12q13, 16p13, 17q21,
19p13, 19q13 and 22q13. Hot-spot loci, for instances, 1q21, where
resided S100As, CD48, and ECM1, as well as 6p21, 19p13 and
19q13 were highlighted. It was of interest to know if genes co-
localized in a hot-spot would interact with those within another
hot-spot. In the antigen presentation pathway, MHC complex,
TAP1 and TNF were located in 6p21, whereas another interacting
gene, CALR, was in the other hot-spot of 19p13. We compared
hot-spots of differential gene activities to those of genomic
alterations reported by Weber and colleagues [2]. Correspond-
ingly, 19p13 region was demonstrated to have loss of heterozy-
gosity in both the stroma and the epithelium compartments of
HNSCC; and 19q13–a stroma-specific locus - was correlated to
the clinical nodal status. Table S3 listed highly reported genes
within the hot-spots of 6p21, 19p13, and 19q13. Bounded fold
changes of the differential gene expression profiles within 6p21
(167 genes) and 19q13 (189 genes) were illustrated across three
progressive stages in Figure 4 c,d. In 6p21.3, HIST1H4s were
found repressed in Pre and TvN; HIST1H2s induced in TvN; and
HIST1H3s repressed in TvN.
Discussion
In order to fully utilize the powerful gene expression profiling,
challenges remained in data integration and in gaining meaningful
insights. The purpose of this meta-analysis aimed at investigating
the transcriptional profiles of HNSCC via a systems-level and
knowledge-based network approach by means of synthesizing
previous research efforts. We showed that gene-gene interplays in
the interacting networks, which were quantitatively analyzed with
topological informational scores and qualitatively visualized with
bounded fold changes, illuminated the underlying biological events
in three progressive stages of HNSCC. To date, we conducted for
the first time a genome-wide meta-analysis in the context of
knowledge-based networks and systematic reviews. We took the
first step to unravel the pathophysiology of HNSCC via a systems-
Table 3. Network Statistics.
Stage Pre TvN Meta
Number of nodes 2084 3383 2101
Number of edges 3484 5401 3266
Ave. degrees 3.32 3.18 3.1
Ave deg of top25% 8.09 7.82 7.56
size of the major component 1911 2155 2025
% of IPA focus genes 71% 76% 75%
Significant hubs (inter) MUC1 CSF2RB DSG3
MARK2 DKK2 HLA-DQB2
CYP1A1 NCF4 TAF11
CYP3A5 NEDD9 RHOG
PRKCB1 RUNX1 BLVRB
Significant hubs (intra) TNF TGFB1 TNC
TGFB1 MYC PI3
MYC IFNG PLAU
TP53 NFkB FN1
NFkB TP53 MMP1
doi:10.1371/journal.pone.0003215.t003
Table 4. Functional estimates of integrins in the integrin signaling networks.
Gene geneID chr siRNA fold.pre fold.tvn fold.meta info.score.tvn
*
ITGA1 3672 5q11.2 29.6 0 0.20619 0 0
ITGA2 3673 5q23-q31 28.9 0 1 20.52905 0
ITGA3 3675 17q21.33 6.1 0 0.19046 0.27718 20
ITGA5 3678 12q11-q13 6.6 0 0.56625 0 26.3
ITGAV 3685 2q31-q32 21.8 0 0.15233 0 0
ITGA6 3655 2q31.1 15.8 0.3295 0.25694 0.54636 0
ITGB1 3688 10p11.2 22.7 0 0.15638 0 4.5
ITGB4 3691 17q25 28 0 0.16508 20.31686 0
Functional estimates of integrins in the integrin signaling networks of the HNSCC transcriptome were highly correlated to the percentage of matrix contraction due to
knockdown of integrins with siRNA in stromal fibroblasts, which in turn should promote the invasion of the co-cultured oral cancer cells, SCC12. The percentages of
matrix contraction due to siRNA depletion were formerly reported by Gaggioli and colleagues [1]. The higher the informational score, i.e. the lower percentage of matrix
contraction due to knockdown of siRNA, indicated a more significant role in the invasion process.
Pearson correlation coefficient=20.86 P-value=0.005.
*Informational scores were derived from the topological analysis of the integrin signaling networks of the HNSCC transcriptome in TvN.
doi:10.1371/journal.pone.0003215.t004
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PLoS ONE | www.plosone.org 8 September 2008 | Volume 3 | Issue 9 | e3215Figure 4. Genome-wide probabilities of the evolving HNSCC transcriptome. a. We computed the accumulative probabilities of reporting
differentially expressed genes within each cytoband along the chromosomal coordinates. Hot-spots of differential gene activities, 1p21, 6p21, 19p13
and 19q13, were highlighted. The standardized accumulative probability for each cytoband was plotted across the genome. The color schemes
represented three progressive stages of the HNSCC transcriptome–red circles: Meta; blue squares: TvN; and green triangles: Pre. b. Co-localization
between hot-spots of differential gene activities and previously implicated regions of genomic alterations by Weber et al. [2]. c–d. Differential gene
expression profiles–bounded fold changes - of 167 genes in 6p21 and 189 genes in 19q13 were plotted along the chromosomal coordinates for the
Pre, TvN and Meta stages, respectively.
doi:10.1371/journal.pone.0003215.g004
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HNSCC research community to make strides in advancing our
knowledge and future progress.
We demonstrated that the perturbation of genes in the
interacting networks could be estimated by the topological
properties. In the enriched antigen presentation and integrin
signaling pathways, we recognized significant roles of CALR,
TAP1, HLA-DQB2, PTEN, HRAS, RHOA, ITGA3 and IT GA5 from
the topological scorings and the differential gene activities in the
evolving HNSCC transcriptome. Remarkably, the estimated
informational scores derived from the integrin signaling networks
not only supported previous findings of Gaggioli et al. [1], but also
extended the functional implication in vivo. Most of the
differentially expressed genes in the antigen presentation and
integrin signaling pathways fell into hot-spot regions of 6p21 and
17q21. Moreover, several highlighted hot-spots of differential gene
activities, such as 19p13 and 19q13, co-localized to previous
implicated regions of genomic alterations by Weber et al. [2].
Thus, we supported and further extended findings from genomic
instabilities to genome-wide differential gene expression profiles.
Disrupted genes exclusively found in each stage of the HNSCC
trascriptome might serve as candidate targets for future cancer
prevention, targeted treatment, or drug discovery. Altogether, we
hope the effort in putting systematic information into perspective
will lead to the medical advancement of HNSCC.
It is of importance to acknowledge that the approach taken in
this meta-analysis, including converting identifiers, standardizing
bounded fold changes, and analyzing the topology of knowledge-
based networks, are innovative but primitive. Therefore, further
experimental efforts to consolidate the demonstrated findings are
crucial. Nonetheless, applying a standard template for each study,
so that the subsequent meta-analyses could be feasible, was indeed
painstaking. Currently, we do not have a standard guideline to
report genome-wide experiments in functional context. As ‘gene’
has become a vague definition and new ‘genon’ concept been
proposed [22], the work presented here might bring about the
initiative to come up with a standard functional format in
reporting genome-wide experiments for future systematic integra-
tion. Furthermore, the limited access to most of the datasets
deserves the HNSCC research community to address issues in
data-sharing and public access. Collectively, the integrative
transcriptome, which orchestrated differential gene expression
profiles, functional annotations, chromosomal coordinates, knowl-
edge-based interactome, and enriched signaling pathways, eluci-
dated the evolving nature of HNSCC. As benefits of conducting
systems-level meta-reviews become clear while future research
advances, we hope to see a more common practice applying the
same strategy in other research areas.
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